TARIFF CLASSIFICATION | 2026-09-04

Section 232 Pharmaceutical Tariffs: 100 Percent Duties Reach California Drug Importers on September 29, 2026

On April 2, 2026, President Trump issued a Section 232 proclamation imposing a 100 percent tariff on imported patented pharmaceuticals and their active ingredients. The tariff took effect on July 31, 2026 for certain named companies and reaches all remaining importers on September 29, 2026, with reduced rates for the United Kingdom, the European Union, and companies that commit to domestic manufacturing.

By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published

On April 2, 2026, President Trump issued a proclamation under Section 232 of the Trade Expansion Act of 1962 imposing a 100 percent tariff on imports of patented, branded pharmaceuticals and their active pharmaceutical ingredients. The tariff applied first to certain named manufacturers on July 31, 2026 and reaches all remaining importers on September 29, 2026, with reduced rates for specified trading partners and generics and biosimilars excluded.

Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.

Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301